Emerging studies on the subtypes of infiltrating immune cells in the brain of MS patients or experimental autoimmune encephalomyelitis (EAE) have revealed that both Th1 and Th17 CD4+ T lymphocytes are involved in disease initiation after in situ reactivation. Here, CD4 is linked to myeloid sarcoma.